ProA Capital’s most common sectors for investment arelife science (12%) and consumer products (12%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (78%) and growth capital (8%). In total, ProA Capital has invested in 2 different countries.
Sign-up to view ProA Capital’s full profile and discover more large private equity firm investors just like it.
Zurbano 76 6th floor,
Madrid,
28010
Spain
+34 913 911 309
www.proacapital.com
info@proacapital.com
| Status | Dates | Company | Description | |
|---|---|---|---|---|
| Investment | Exit | |||
| Current | 2024-10-08 | - |
Adventia Pharma
Life Science Las Palmas de Gran Canaria, Spain www.adventiapharma.com |
Adventia Pharma is a pharmaceutical and clinical-nutrition company specializing in the development, manufacture, and commercialization of medical nutrition products, food supplements, and health-focused solutions, serving hospitals and healthcare providers with innovative, patient-centered offerings. Adventia Pharma was founded in 2010 and is based in Las Palmas de Gran Canaria, Spain. |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
